Silver nanoparticles: The powerful nanoweapon against multidrug-resistant bacteria

Journal of Applied Microbiology

Volumn 112, Issue 5, 2012, Pages 841-852

  Rai, M K ^a   Deshmukh, S D ^a   Ingle, A P ^a   Gade, A K ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Antimicrobial; Methicillin resistant Staphylococcus aureus; Multidrug resistance; Nanoweapon; Silver nanoparticles; Vancomycin resistant Staphylococcus aureus

Indexed keywords

ANTIBIOTICS; BACTERIA; DRUG DELIVERY; METAL NANOPARTICLES;

ANTIBIOTICS RESISTANCE; ANTIMICROBIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANTS; NANOWEAPON; RESISTANT BACTERIA; RESISTANT STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN-RESISTANT STAPHYLOCOCCUS AUREUS;

SILVER NANOPARTICLES;

ALGINATE NANOPARTICLE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CELLULOSE; CEPHALOSPORIN; CLINDAMYCIN; COPPER NANOPARTICLE; ERYTHROMYCIN; EYE DROPS; FLUCONAZOLE; FUNGICIDE; GENTAMICIN; GOLD NANOPARTICLE; MAGNESIUM NANOPARTICLE; PENICILLIN G; SILVER NANOPARTICLE; SILVER NITRATE; SILVER ZEOLITE; STREPTOMYCIN; SULFADIAZINE SILVER; TETRACYCLINE; TITANIUM NANOPARTICLE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; ZINC NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM; MORBIDITY; MORTALITY; NANOTECHNOLOGY; PATHOGEN; PHARMACEUTICAL INDUSTRY; SILVER;

ALTERNARIA ALTERNATA; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; ASPERGILLUS; AYURVEDA; BACILLUS SUBTILIS; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BONE DISEASE; BURN; CANDIDA; CANDIDA ALBICANS; COLONY FORMING UNIT; CREAM; DISINFECTION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BINDING; DRUG PENETRATION; DRUG POTENTIATION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; ESCHERICHIA COLI; FOOD PRESERVATION; FUNGICIDAL ACTIVITY; FUNGUS; FUSARIUM; FUSARIUM ACUMINATUM; FUSARIUM OXYSPORUM; GONORRHEA; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HUMAN IMMUNODEFICIENCY VIRUS 1; INSTRUMENT STERILIZATION; INTRACELLULAR SIGNALING; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR SIZE; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT BACTERIUM; MURRAYA KOENIGII; NEWBORN OPHTHALMIA; NONHUMAN; PERIANAL ABSCESS; PHOMA GLOMERATA; PHOMA HERBARUM; PHYSICAL CHEMISTRY; PSEUDOMONAS AERUGINOSA; REVIEW; SACCHAROMYCES; SALIVARY GLAND DISEASE; SALMONELLA TYPHI; SEXUALLY TRANSMITTED DISEASE; SHIGELLA FLEXNERI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS MUTANS; TRICHODERMA; VIRUS INHIBITION; VIRUS REPLICATION; WOUND DRESSING; WOUND HEALING;

BACTERIA (MICROORGANISMS); METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 84859621403     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2012.05253.x     Document Type: Review

References (76)

1. Abraham, E.P. and Chain, E. (1940) An enzyme from bacteria able to destroy Penicillin. Nature 146, 837.
2. Ahmad, Z., Pandey, R., Sharma, S. and Khuller, G.K. (2005) Alginate nanoparticles as antituberculosis drug carriers: formulation development, pharmacokinetics and therapeutic potential. Indian J Chest Dis Allied Sci 48, 171-176.
3. Ansari, M.A., Khan, H.M., Khan, A.A., Malik, A., Sultan, A., Shahid, M., Shujatullah, F. and Azam, A. (2011) Evaluation of antibacterial activity of silver nanoparticles against MSSA and MSRA on isolates from skin infections. Biol Med 3, 141-146.
4. Atiyeh, B.S., Costagliola, M., Hayek, S.N. and Dibo, S.A. (2007) Effect of silver on burn wound infection control and healing: review of the literature. Burn 33, 139-148.
5. Ayala-Nunez, N.V., Villegas, H.H.L., Turrent, L.C.I. and Padilla, C.R. (2009) Silver nanoparticles toxicity and bactericidal effect against methicillin resistant Staphylococcus aureus: nanoscale does matter. Nanobiotechnology 5, 2-9.
6. Baker, C., Pradhan, A., Pakstis, L., Pochan, D.J. and Shah, S.I. (2005) Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol 2, 244-249.
7. Bellinger, C.G. and Conway, H. (1970) Effects of silver nitrate and sulfamylon on epithelial regeneration. Plast Reconstr Surg 45, 582-585.
8. Bhol, K.C., Alroy, J. and Schechter, P.J. (2004) Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol 29, 282-287.
9. Birla, S.S., Tiwari, V.V., Gade, A.K., Ingle, A.P., Yadav, A.P. and Rai, M.K. (2009) Fabrication of silver nanoparticles by Phoma glomerata and its combined effect against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. Lett Appl Microbiol 48, 173-179.
10. Biyela, P.T., Lin, J. and Bezuidenhout, C.C. (2004) The role of aquatic ecosystems as reservoirs of antibiotic resistant bacteria and antibiotic resistance genes. Water Sci Technol 50, 45-50.
11. Bonde, S.R., Rathod, D.P., Ingle, A.P., Ade, R.B., Gade, A.K. and Rai, M.K. (2012) Murraya koenigii-mediated synthesis of silver nanoparticles and its activity against three human pathogenic bacteria. Nanosci Meth 1, 25-36.
12. Butkus, M.A., Labare, M.P., Starke, J.A., Moon, K. and Talbot, M. (2004) Use of aqueous silver to enhance inactivation of coliphage MS-2 by UV disinfection. Appl Environ Microbiol 70, 2848-2853.
13. Castellano, J.J., Shafii, S.M., Ko, F., Donate, G., Wright, T.E., Mannari, R.J., Payne, W.G., Smith, D.J. et al. (2007) Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J 4, 14-22.
14. Cebrian, L.E., Sirvent, J.C., Rodriguez, D., Ruiz, M. and Royo, G. (2003) Characterisation of Salmonella spp. mutants produced by exposure to various fluoroquinolones. Int J Antimicrob Agents, 22, 134-139.
15. Chen, X. and Schluesener, H.J. (2008) Nano-silver: a nanoproduct in medical application. Toxicol Lett 176, 1-12.
16. Chopra, I. (2007) The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern. J Antimicrob Chemother 59, 587-590.
17. De Souza, A., Mehta, D. and Leavitt, R.W. (2006) Bactericidal activity of combinations of silver-water dispersion with 19 antibiotics against seven microbial strains. Curr Sci, 91, 926-929.
18. Duran, N., Marcarto, P.D., De Souza, G.I.H., Alves, O.L. and Esposito, E. (2007) Antibacterial effect of silver nanoparticles produced by fungal process on textile fabrics and their effluent treatment. J Biomed Nanotechnol 3, 203-208.
19. Espinosa-Cristobal, L.F., Martinez-Castanon, G.A., Martinez-Martinez, R.E., Loyola-Rodriguez, J.P., Patino-Marin, N., Reyes-Macias, J.F. and Ruiz, F. (2009) Antibacterial effect of silver nanoparticles against Streptococcus mutans. Mater Lett 63, 2603-2606.
20. Falagas, M.E., Grammatikos, A.P. and Michalopoulos, A. (2008) Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 6, 593-600.
21. Feng, Q.L., Wu, J., Chen, G.Q., Cui, F.Z., Kim, T.N. and Kim, J.O. (2000) Mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 52, 662-668.
22. Gade, A., Gaikwad, S., Tiwari, V., Yadav, A., Ingle, A. and Rai, M. (2010) Biofabrication of silver nanoparticles by Opuntia ficus-indica: in vitro antibacterial activity and study of the mechanism involved in the synthesis. Curr Nanosci 6, 370-375.
23. Gajbhiye, M., Kesharwani, J., Ingle, A., Gade, A. and Rai, M. (2009) Fungus-mediated synthesis of silver nanoparticles and their activity against pathogenic fungi in combination with fluconazole. Nanomedicine 5, 382-386.
24. Geethalakshmi, R. and Sarada, D.V.L. (2010) Synthesis of plant-mediated silver nanoparticles using Trianthema decandra extract and evaluation of their anti microbial activities. Int J Eng Sci Technol 2, 970-975.
25. Gemmell, C.G., Edwards, D.I. and Frainse, A.P. (2006) Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57, 589-608.
26. 4@Ag nanoparticles. Nanotechnology 18, 604-611.
27. Govindaraju, K., Tamilselvan, S., Kiruthiga, V. and Singaravelu, G. (2010) Biogenic silver nanoparticles by Solanum torvum and their promising antimicrobial activity antimicrobial activity of silver nanoparticles. J. Biopest. 3, 394-399.
28. Gu, H., Ho, P.L., Tong, E., Wang, L. and Xu, B. (2003) Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett 3, 1261-1263.
29. Hernane, S.B., Regiani, T., Marques, R.F.C., Lustri, W.R., Messaddeq, Y. and Ribeiro, S.J.L. (2011) Antimicrobial bacterial cellulose-silver nanoparticles composite membranes. J. Nanomate. 721, 631-639.
30. Hooper, D.C. (2000) Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 31, S24-S28.
31. Humberto, H., Lara, V., Ayala-Nunez, N.V., Carmen, L.D., Ixtepan, T. and Cristina, R.P. (2010) Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol 26, 615-621.
32. Hwang, E.T., Lee, J.H., Chae, Y.J., Kim, Y.S., Kim, B.C., Sang, B. and Gu, M.B. (2008) Analysis of the toxic mode of action of silver nanoparticles using stress-specific bioluminescent bacteria. Small 4, 746-750.
33. Ingle, A., Gade, A., Pierrat, S., Sonnichsen, C. and Rai, M. (2008) Mycosynthesis of silver nanoparticles using the fungus Fusarium acuminatum and its activity against some human pathogenic bacteria. Curr Nanosci 4, 141-144.
34. Jun, J., Yuan-Yuan, D., Shao-hai, W., Shao-feng, Z. and Zhongyi, W. (2007) Preparation and characterization of antibacterial silver-containing nanofibers for wound dressing applications. J US China Med Sci 4, 52-54.
35. Kawahara, K., Tsuruda, K., Morishita, M. and Uchida, M. (2000) Antibacterial effect of silver zeolite on oral bacteria under anaerobic condition. Dent Mater 16, 452-455.
36. Kim, J.S., Kuk, E., Yu, K.N., Kim, J.H., Park, S.J., Lee, H.J., Jeong, D.H. and Cho, M.H. (2007) Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol Biol Med 3, 95-101.
37. Ki-Young, N. (2011) In vitro antimicrobial effect of the tissue conditioner containing silver nanoparticles. J Adv Prosthodont 3, 20-24.
38. Klueh, U., Wagner, V., Kelly, S., Johnson, A. and Bryers, J.D. (2000) Efficacy of silver-coated fabric to prevent bacterial colonization and subsequent device-based biofilm formation. J Biomed Mater Res 53, 621-631.
39. Knetsch, M.L.W. and Leo, H.K. (2011) New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers 3, 340-366.
40. Kotra, L.P., Haddad, J. and Mobashery, S. (2000) Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob Agents Chemother 44, 3249-3256.
41. Landsdown, A.B.G. (2002) Silver I: its antibacterial properties and mechanism of action. J Wound Care 11, 125-138.
42. Lkhagvajav, N., Yasab, I., Çelikc, E., Koizhaiganova, M. and Saria, O. (2011) Antimicrobial activity of colloidal silver nanoparticles prepared by sol gel method. Dig J Nanomater Biostruct 6, 149-154.
43. Lok, C.N., Ho, C.M., Chen, R., He, Q.Y., Yu, W.Y., Sun, H., Kwong-Hang, P., Chiu, T.J. et al. (2006) Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J Proteome Res 5, 916-924.
44. Maneerung, T., Tokura, S. and Rujiravanit, R. (2008) Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing. Carbohydr Polym 72, 43-51.
45. Maple, P.A.C., Hamilton-Miller, J.M.T. and Brranfltt, W. (1992) Comparison of the in-vitro activities of the topical antimicrobials azelaic and, nitroforazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 29, 661-668.
46. Marcato, P.D. and Duran, N. (2008) New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol 8, 2216-2229.
47. Matsumura, Y., Yoshikata, K., Kunisaki, S.I. and Tsuchido, T. (2003) Mode of bactericidal action of silver zeolite and its comparison with that of silver nitrate. Appl Environ Microbiol 69, 4278-4281.
48. Mcdonnell, G. and Russell, D. (1999) Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12, 147-179.
49. Morones, J.R., Elechiguerra, J.L., Camacho, A. and Ramirez, J.T. (2005) The bactericidal effect of silver nanoparticles. Nanotechnology 16, 2346-2353.
50. Moyer, C.A., Brentano, L., Gravens, D.L., Margraf, H.W. and Monafo, W.W. (1965) Treatment of large human burns with 0.5% silver nitrate solution. Arch Surg 90, 812-867.
51. Namasivayam, S.K.R., Ganesh, S. and Avimanyu, B. (2011) Evaluation of anti-bacterial activity of silver nanoparticles synthesized from Candida glabrata and Fusarium oxysporum. Int J Med Res 1, 131-136.
52. Nanda, A. and Saravanan, M. (2009) Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine 5, 452-456.
53. Nithya, G.N., Shepangam, H. and Balaji, S. (2011) Biosynthesis of silver nanoparticle and its antibacterial activity. Arch Appl Sci Res 3, 377-380.
54. Oberdorster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J. and Ausman, K. (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Part Fibre Toxicol 2, 38-43.
55. Pal, S., Tak, Y.K. and Song, J.M. (2007) Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl Environ Microbiol 27, 1712-1720.
56. Panacek, A., Kvitek, L., Prucek, R., Kolar, M., Vecerova, R., Pizurova, N., Sharma, V.K., Nevecna, T. et al. (2006) Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem 110, 16248-16253.
57. Percival, S.L., Bowler, P.G. and Dolman, J. (2007) Antimicrobial activity of silver-containing dressings on wound microorganisms using an in vitro biofilm model. Int Wound J, 4, 186-191.
58. Poole, K. (2004) Resistance to beta-lactam antibiotics. Cell Mol Life Sci 61, 2200-2223.
59. Rai, M., Yadav, A. and Gade, A. (2009) Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv 27, 76-83.
60. Raimondi, F., Scherer, G.G., Kotz, R. and Wokaun, A. (2005) Nanoparticles in energy technology: examples from electrochemistry and catalysis. Angew Chem Int Ed Engl 44, 2190-2209.
61. Saravanan, M. and Nanda, A. (2010) Extracellular synthesis of silver bionanoparticles from Aspergillus clavatus and its antimicrobial activity against MRSA and MRSE. Coll Surfaces B Biointerfaces 77, 214-218.
62. Shahverdi, A.R., Fakhimi, A., Shahverdi, H.R. and Minaian, S. (2007) Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli. Nanomedicine 3, 168-171.
63. Shrivastava, S., Bera, T., Roy, A., Singh, G., Ramachandrarao, P. and Dash, D. (2008) Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnol. 18, 103-112.
64. Silvestry-Rodriguez, N., Sicairos-Ruelas, E.E., Gerba, C.P. and Bright, K.R. (2007) Silver as a disinfectant. Rev Environ Contam Toxicol 191, 23-45.
65. Singh, R. and Singh, N.H. (2011) Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J Biomed Nanotechnol 7, 489-503.
66. Slonczewski, J. and Foster, J. (2009) Microbiology: An Evolving Science. New York: W.W. Norton & Company.
67. Sondi, I. and Salopek-Sondi, B. (2007) Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interface Sci 275, 77-82.
68. Spacciapoli, P., Buxton, D., Rothstein, D. and Friden, P. (2001) Antimicrobial activity of silver nitrate against periodontal pathogens. J Periodontal Res 36, 108-113.
69. Stefan, M., Lucian, H., Marius, M., Daniela, P., Irina, G., Romeo-Iulian, O., Simona, D. and Viorel, M. (2011) Enhanced antibacterial effect of silver nanoparticles obtained by synthesis in poly amide-hydroxyurethane media. J Mater Sci Mater Med 22, 789-796.
70. Sun, R.W., Chen, R., Chung, N.P., Ho, C.M., Lin, C.L. and Che, C.M. (2005) Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun (Camb) 40, 5059-5061.
71. Susan, W.P.W., Willie, J.J.M., Carla, A.H., Werner, I.H., Heugens, E.H.W., Roszek, B., Bisschops, J., Gosens, I. et al. (2009) Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3, 109-138.
72. Tenover, F.C. (2006) Mechanisms of antimicrobial resistance in bacteria. Am J Med 119, S3-S10.
73. Tian, J., Wong, K.K., Ho, C.M., Lok, C.N., Yu, W.Y., Che, C.M., Chiu, J.F. and Tam, P.K. (2007) Topical delivery of silver nanoparticles promotes wound healing. Chem Med Chem 2, 129-136.
74. Warheit, D.B., Borm, P.J., Hennes, C. and Lademann, J. (2007) Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol 19, 631-643.
75. Webb, G.F., D'Agata, E.M., Magal, P. and Ruan, S. (2005) A model of 499 antibiotic-resistant bacterial epidemics in hospitals. Proc Nat Acad Sci 102, 13343-13348.
76. Yamanaka, M., Hara, K. and Kudo, J. (2005) Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl Environ Microbiol 71, 7589-7593.